Galera Therapeutics Inc

NASDAQ:GRTX  
10.90
+0.07 (+0.65%)
Other Pre-Announcement

Galera Therapeutics Reports Q3 Loss Per Share $0.69

Published: 11/10/2020 13:08 GMT
Galera Therapeutics Inc. (GRTX) - Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates.
Q3 Loss per Share $0.69.
Q3 Earnings per Share Estimate $-0.77 -- Refinitiv Ibes Data (analyst estimates).
Galera Therapeutics - Expects Existing Cash Resources With Expected Payments Will Fund Operating Expenses and Capital Expenditure Into H2 of 2022.